ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Pediatric CCP Controversy Splits Group Leaders; National Consortium Forms; NCAB to Watch Closely

January 14, 1983

NCI’s Kramer Named Director, NIH Medical Applications Office.

June 16, 2000

Komen Foundation Calls For Review Of Action Plan’s Goals

October 24, 1996

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

In Brief: Kennedy Drops Health Care Institute Plan Senate Approves Dole Amendment On Patents

August 18, 1978

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

October 26, 2007